Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.04% Nasdaq Down 0.76%
Streaming
Ticker Tape: On

Poniard Pharmaceuticals, Inc. (PARD)

-Other OTC
0.21 Down 0.11(34.34%) 9:36AM EDT
Get the big picture on all your investments.
Prev Close:0.32
Open:0.21
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.07
Next Earnings Date:N/A
Day's Range:0.21 - 0.21
52wk Range:0.20 - 0.56
Volume:137
Avg Vol (3m):2,705
Market Cap:314.94K
P/E (ttm):N/A
EPS (ttm):-3.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PARD

Reports

Comparison

Symbol% ChgMkt Cap
PARDDown 34.34%314.94K
BMYUp 0.05%84.19B
IMGNDown 4.53%1.19B
SNYDown 0.13%140.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Mar-11) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback